Dsm Pharmaceutical Products

DSM to merger pharma business with Patheon

update

DSM plans to merge pharma business with Patheon

By Gareth Macdonald

Royal DSM wants to merge its pharmaceutical products business with Patheon and has signed a deal with the latter's owner, investment group JLL Partners.

DSM to Supply Cancer Drug for Eisai

DSM to Supply Cancer Drug for Eisai

By Dan Stanton

Eisai says its US supply agreement with DSM offers an alternate manufacturing facility and ensures a strengthened supply line.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers